Beyond Biopharma: A Comprehensive Look at the COVID-19 Vaccine Supply Chain
September 10, 2020
“Heading into the Fall, there is a significant market focus on COVID-19 vaccine development in order to bring society back to “normal.” The impact of COVID-19 has been staggering, with >26mm cases worldwide and >860K deaths geographically spread around the world. The stakes for a vaccine are high, and the whole world is watching.”
– Team Nephron
In a 69-page report and follow up conference call earlier this week, the Nephron team provided subscribers with a comprehensive review of the impact of COVID-19 on the supply chain – beyond the biopharma sponsors. Nephron’s organic, cross-sector research process was on display as Jack Meehan, Eric Percher, and Josh Raskin seamlessly moved through the broader supply chain assessment. In particular, the team looked at the following areas of impact and specific $ opportunities:
- Factors to Consider When Evaluating the Potential for Vaccines
- Overview on the COVID-19 Vaccine Landscape
- CROs
- CDMOs
- Bioprocessing
- Distributors
- Pharmacies
- Managed Care
Reach out to info@nephronresearch.com to learn more about subscribing to Nephron Research.